ALBERTDAVD850.00

Albert David Limited

· Pharma & Health
₹ CrorePeersVALIANTLABHALEOSLABSZIMLABMEDICOMEDICAMEQANUHPHRAHCLWANBURYMcap ₹485 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
ALBERTDAVD
FY26
VALIANTLAB
FY26
HALEOSLABS
FY26
ZIMLAB
FY26
Peer
Median
Valuation — at last close
P/E25.32×115.29×70.31×
P/B1.24×1.91×2.48×2.19× -44%
EV/EBITDA52.73×12.22×27.72×19.97× +164%
Market Cap₹485 Cr₹438 Cr₹734 Cr₹586 Cr -17%
Growth
Revenue CAGR 3Y-0.78%1.89%-2.06%-0.09% -818%
Revenue CAGR 5Y6.16%4.68%4.68% +32%
Net Income CAGR 3Y16.09%-37.95%-10.93%
Revenue YoY (latest Q)43.60%146.22%-11.59%31.25%31.25% +40%
Net Income YoY (latest Q)303.12%1058.93%-58.00%-114.25%-58.00% +623%
Profitability
EBITDA Margin1.64%2.69%13.38%8.02%8.02% -80%
Net Income Margin-0.45%-1.38%5.33%1.56%1.56% -129%
Return on Common Equity-0.38%-1.05%7.54%1.97%1.97% -119%
Return on Capital Employed-1.06%0.10%9.80%2.87%2.87% -137%
Return on Assets-0.29%-0.70%3.92%1.08%1.08% -127%
Credit & Quality
Total Debt/Equity0.07×0.14×0.47×0.42×0.42× -83%
Interest Coverage-1.63×0.18×4.53×0.76×0.76× -314%
Scale — latest FY
Revenue / Total Income₹334 Cr₹237 Cr₹334 Cr₹374 Cr₹334 Cr -0%
Net Income−₹1.5 Cr−₹3.3 Cr₹17.8 Cr₹5.8 Cr₹5.8 Cr -126%
Total Assets₹519 Cr₹464 Cr₹454 Cr₹539 Cr₹464 Cr +12%
EPS₹-2.62₹-0.51₹57.26₹1.19₹1.19 -320%
Book Value per Share₹686.04₹57.24₹759.29₹55.36₹57.24 +1099%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.